The Ongoing Evolution of Anti-VEGF Therapy: A Detailed Examination...

Ajouter une nouvelle offre d'emploi Health

2025-10-24 13:05:48 - Traduire

The Ongoing Evolution of Anti-VEGF Therapy: A Detailed Examination of the Eylea Market analysis and Its Competitive Positioning Against Biosimilars and Next-Generation Treatments

The Eylea market, centered around the anti-VEGF agent aflibercept, remains a powerhouse in the treatment of major retinal diseases like wet age-related macular degeneration (wAMD) and diabetic macular edema (DME), yet it stands at a critical juncture driven by fierce competitive and regulatory pressures. The therapy’s established efficacy, proven across numerous clinical trials...

0 Commentaires 0 Parts 113 Vue 0 Aperçu